Keybank National Association Intra Cellular Therapies, Inc. Transaction History

Keybank National Association

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$10.36 - $20.96 $138,596 - $280,402	-13,378 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$17.77 - $22.9 $66,388 - $85,554	-3,736 Reduced 21.83%	13,378 $290,000
Q1 2018 May 15, 2018	SELL	$15.16 - $25.49 $72,631 - $122,122	-4,791 Reduced 21.87%	17,114 $360,000
Q4 2017 Feb 08, 2018	BUY	$14.27 - $16.79 $4,837 - $5,691	339 Added 1.57%	21,905 $317,000
Q3 2017 Nov 02, 2017	SELL	$10.77 - $22.1 $64,458 - $132,268	-5,985 Reduced 21.72%	21,566 $340,000
Q2 2017 May 14, 2018	BUY	N/A	7,503 Added 37.43%	27,551 $342,000
Q4 2016 May 14, 2018	BUY	N/A	20,048	20,048 $303,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.09B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.